Endothelium-derived vasoactive substances and uterine blood vessels.
Magness
R R
RR
Department of Pediatrics and Obstetrics/Gynecology, University of Texas Southwestern Medical Center, Dallas 75235.
D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D000242:Cyclic AMP / Q000378:metabolism; D006152:Cyclic GMP / Q000502:physiology; D004730:Endothelium, Vascular / Q000378:metabolism; D011464:Epoprostenol / Q000502:physiology*; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007213:Indomethacin / Q000494:pharmacology; D009131:Muscle, Smooth, Vascular / Q000502:physiology; D009569:Nitric Oxide / Q000502:physiology*; D011247:Pregnancy / Q000502:physiology*; D011270:Pregnancy, Animal / Q000502:physiology*; D012756:Sheep; D014599:Uterus / Q000098:blood supply*
D000804:Angiotensin II; D009569:Nitric Oxide; D011464:Epoprostenol; D000242:Cyclic AMP; D006152:Cyclic GMP; D007213:Indomethacin